ASURAGEN, INC.

Acquired

Molecular Diagnostics, Genetics & Oncology Testing

AUSTIN, United States · Founded 2015 · $80.0M raised

Headquarters
AUSTIN, Texas
Employees
51–200
Founded
2015
Business Model
B2B
Total Funding
$80.0M
Last Round
$18.5M GrantJan 2015

About

Asuragen is a molecular diagnostic product company focused on genetics and oncology testing. It develops PCR-based and next-generation sequencing kits for detecting genetic mutations associated with conditions such as spinal muscular atrophy, Huntington's disease, and chronic myeloid leukemia. Asuragen operates as a brand under Bio-Techne Corporation following an acquisition.

Summary

ASURAGEN, INC. is a Biotech company based in AUSTIN, United States, founded in 2015. It has raised $80.0M in total, most recently a $18.5M Grant round in Jan 2015.

Funding History

No funding data available yet.

Know something? Help us improve our data.

Similar Companies